Table 2: Clinical and Biochemical Results. | |||||
Results Parameters |
L+A(n=16 wk 24 ,n=15 wk 48) |
T(n=16) |
E(n=16 ) |
P value |
|
C T P score ≥2 decrease |
|||||
At week 24 |
3(20%)s |
6(37.5%) |
7(43.8%) |
0.181 |
|
At week 48 |
6(40%) |
7(43.8%) |
10(62.5%) |
0.133 |
|
CTP score- change in CTP |
|||||
At week 24 |
0.69 ±o.94 |
1.50 ±1.673 |
1.56±1.153 |
0.116 |
|
At week 48 |
1.33 ±1.05 |
1.94±1.57 |
2.00±1.37 |
0.326 |
|
Decrease in MELD score |
|||||
At week 24 |
1.4 ±3.36 |
2.0±3.25 |
2.4±1.82 |
0.620 |
|
At week 48 |
1.7 ±2.36 |
2.4±3.89 |
2.7±1.87 |
0.611 |
|
Change in serum HBV DNA (median log decrease) |
|||||
At week 24 |
2.60 ±1.35 |
3.06±1.88 |
2.69±1.35 |
0.674 |
|
At week 48 |
3.73 ±1.39 |
3.94±1.88 |
3.31±1.82 |
0.577 |
|
HBV DNA undetectable (%) |
|||||
At week 24 |
8(48%) |
8 (50%) |
10(60%) |
0.717 |
|
At week 48 |
10 (67%) |
10(62%) |
12(75%) |
0.815 |
|
Serological Response |
|||||
HBeAg loss |
|||||
At week 48 |
2(50%))(n=4) |
2(50%)(n=4) |
2((66%)(n=3) |
0.885 |